← Back
Data updated: Mar 10, 2026
SWEDISH ORPHAN
ImmunologyRare Disease
SWEDISH ORPHAN is a specialty pharmaceutical company focused on Immunology, Rare Disease.
1998
Since
2
Drugs
-
Trials
0
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
No recent activity
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 89%
0 drugs Phase 3: 1 Phase 2: 2
Rare Disease 11%
0 drugs Phase 1: 1
Pipeline Strength Pro
Loading...